Dopamine down-regulation of protein L-isoaspartyl methyltransferase is dependent on reactive oxygen species in SH-SY5Y cells

Neuroscience

Volumn 267, Issue , 2014, Pages 263-276

  Ouazia, D ^a   Levros, L C ^a   Rassart, É ^a   Desrosiers, R R ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Dopamine; Oxidative stress; Parkinson's disease; PCMT1; PIMT; Protein L isoaspartyl methyltransferase

Indexed keywords

ACETYLCYSTEINE; DOPAMINE; MESSENGER RNA; PROTEIN L ISOASPARTYL METHYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; REGULATOR PROTEIN; UNCLASSIFIED DRUG; ANTIOXIDANT; AROMATIC HYDROCARBON RECEPTOR; CATALASE; HYDROGEN PEROXIDE; INSECTICIDE; PROTEIN DEXTRO ASPARTATE METHYLTRANSFERASE; ROTENONE;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOWN REGULATION; GENE; GENE DELETION; GENE EXPRESSION REGULATION; GENE MAPPING; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NEUROBLASTOMA CELL; OXIDATIVE STRESS; PCMT1 GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN L ISOASPARTYL METHYLTRANSFERASE GENE; PROTEIN LOCALIZATION; REGULATOR GENE; TRANSCRIPTION INITIATION SITE; UPREGULATION; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; METABOLISM; MUTATION; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

ANTIOXIDANTS; CATALASE; CELL LINE, TUMOR; CELL SURVIVAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; HUMANS; HYDROGEN PEROXIDE; INSECTICIDES; MUTATION; NEUROBLASTOMA; PROMOTER REGIONS, GENETIC; PROTEIN D-ASPARTATE-L-ISOASPARTATE METHYLTRANSFERASE; REACTIVE OXYGEN SPECIES; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; ROTENONE; TRANSFECTION;

EID: 84897467873     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.03.001     Document Type: Article

References (62)

1. Akahoshi E., Yoshimura S., Ishihara-Sugano M. Over-expression of AhR (aryl hydrocarbon receptor) induces neural differentiation of Neuro2a cells: neurotoxicology study. Environ Health 2006, 7(5):24.
2. Alberio T., Bossi A.M., Milli A., Parma E., Gariboldi M.B., Tosi G., Lopiano L., Fasano M. Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis. FEBS J 2010, 277:4909-4919.
3. Alter S.P., Lenzi G.M., Bernstein A.I., Miller G.W. Vesicular integrity in Parkinson's disease. Curr Neurol Neurosci Rep 2013, 13:362.
4. Asanuma M., Miyazaki I., Ogawa N. Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotox Res 2003, 5:165-176.
5. Betarbet R., Sherer T.B., MacKenzie G., Garcia-Osuna M., Panov A.V., Greenamyre J.T. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci 2000, 3:1301-1306.
6. Billingsley M.L., Balaban C.D. Protein-O-carboxylmethyltransferase in the rat brain: high regional levels in the substantia nigra, locus coeruleus and paraventricular nucleus. Brain Res 1985, 358:96-103.
7. Blesa J., Phani S., Jackson-Lewis V., Przedborski S. Classic and new animal models of Parkinson's disease. J Biomed Biotechnol 2012, 2012:845618.
8. Blum D., Torch S., Nissou M.F., Benabid A.L., Verna J.M. Extracellular toxicity of 6-hydroxydopamine on PC12 cells. Neurosci Lett 2000, 283:193-196.
9. Boivin D., Gingras D., Béliveau R. Purification and characterization of a membrane-bound protein carboxyl methyltransferase from rat kidney cortex. J Biol Chem 1993, 268:2610-2615.
10. Chalovich E.M., Zhu J.H., Caltagarone J., Bowser R., Chu C.T. Functional repression of cAMP response element in 6-hydroxydopamine-treated neuronal cells. J Biol Chem 2006, 281:17870-17881.
11. Cimmino A., Capasso R., Muller F., Sambri I., Masella L., Raimo M., De Bonis M.L., D'Angelo S., Zappia V., Galletti P., Ingrosso D. Protein isoaspartate methyltransferase prevents apoptosis induced by oxidative stress in endothelial cells: role of Bcl-Xl deamidation and methylation. PLoS One 2008, 3:e3258.
12. Clarke S. Aging as war between chemical and biochemical processes: protein methylation and the recognition of age-damaged proteins for repair. Ageing Res Rev 2003, 2:263-285.
13. Colapinto M., Mila S., Giraudo S., Stefanazzi P., Molteni M., Rossetti C., Bergamasco B., Lopiano L., Fasano M. Alpha-synuclein protects SH-SY5Y cells from dopamine toxicity. Biochem Biophys Res Commun 2006, 349:1294-1300.
14. Cueille N., Blanc C.T., Riederer I.M., Riederer B.M. Microtubule-associated protein 1B binds glyceraldehyde-3-phosphate dehydrogenase. J Proteome Res 2007, 6:2640-2647.
15. Dean O., Giorlando F., Berk M. N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 2011, 36:78-86.
16. Desrosiers R.R., Fanélus I. Damaged proteins bearing L-isoaspartyl residues and aging: a dynamic equilibrium between generation of isomerized forms and repair by PIMT. Curr Aging Sci 2011, 4:8-18.
17. DeVry C.G., Tsai W., Clarke S. Structure of the human gene encoding the protein repair L-isoaspartyl (D-aspartyl) O-methyltransferase. Arch Biochem Biophys 1996, 335:321-332.
18. dos Santos N.A., Martins N.M., Curti C., Pires Bianchi Mde L., dos Santos A.C. Dimethylthiourea protects against mitochondrial oxidative damage induced by cisplatin in liver of rats. Chem Biol Interact 2007, 170:177-186.
19. Fanélus I., Desrosiers R.R. Mitochondrial uncoupler carbonyl cyanide m-chlorophenylhydrazone induces the multimer assembly and activity of repair enzyme protein L-isoaspartyl methyltransferase. J Mol Neurosci 2013, 50:411-423.
20. Faure J.J., Hattingh S.M., Stein D.J., Daniels W.M. Proteomic analysis reveals differentially expressed proteins in the rat frontal cortex after methamphetamine treatment. Metab Brain Dis 2009, 24:685-700.
21. Filloux F., Townsend J.J. Pre- and postsynaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection. Exp Neurol 1993, 119:79-88.
22. Giménez-Xavier P., Gómez-Santos C., Castaño E., Francisco R., Boada J., Unzeta M., Sanz E., Ambrosio S. The decrease of NAD(P)H has a prominent role in dopamine toxicity. Biochim Biophys Acta 2006, 1762:564-574.
23. Giménez-Xavier P., Francisco R., Santidrián A.F., Gil J., Ambrosio S. Effects of dopamine on LC3-II activation as a marker of autophagy in a neuroblastoma cell model. Neurotoxicology 2009, 30:658-665.
24. Gómez-Santos C., Barrachina M., Giménez-Xavier P., Dalfó E., Ferrer I., Ambrosio S. Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage. Brain Res Bull 2005, 65:87-95.
25. Greene J.G., Dingledine R., Greenamyre J.T. Gene expression profiling of rat midbrain dopamine neurons: implications for selective vulnerability in parkinsonism. Neurobiol Dis 2005, 18:19-31.
26. Guyot E., Chevallier A., Barouki R., Coumoul X. The AhR twist: ligand-dependent AhR signaling and pharmaco-toxicological implications. Drug Discov Today 2013, 18:479-486.
27. Hastings T.G. The role of dopamine oxidation in mitochondrial dysfunction: implications for Parkinson's disease. J Bioenerg Biomembr 2009, 41:469-472.
28. Higashi Y., Asanuma M., Miyazaki I., Hattori N., Mizuno Y., Ogawa N. Parkin attenuates manganese-induced dopaminergic cell death. J Neurochem 2004, 89:1490-1497.
29. Iglesias-González J., Sánchez-Iglesias S., Méndez-Álvarez E., Rose S., Hikima A., Jenner P., Soto-Otero R. Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase. Neurochem Res 2012, 37:2150-2160.
30. Inoue K., Ito Y. Neuroblastoma cell proliferation is sensitive to changes in levels of RUNX1 and RUNX3 protein. Gene 2011, 487:151-155.
31. Jiang Y., Pei L., Li S., Wang M., Liu F. Extracellular dopamine induces the oxidative toxicity of SH-SY5Y cells. Synapse 2008, 62:797-803.
32. Junn E., Mouradian M.M. Apoptotic signaling in dopamine-induced cell death: the role of oxidative stress, p38 mitogen-activated protein kinase, cytochrome c and caspases. J Neurochem 2001, 78:374-383.
33. Khare S., Gomez T., Linster C.L., Clarke S.G. Defective responses to oxidative stress in protein l-isoaspartyl repair-deficient Caenorhabditis elegans. Mech Ageing Dev 2009, 130:670-680.
34. Kim S.Y., Woo M.S., Park J.S., Kim H.S. Regulation of matrix metalloproteinase-9 gene expression in MPP+- or 6-OHDA-treated human neuroblastoma SK-N-BE(2)C cells. Neurochem Int 2010, 56:437-442.
35. Kita T., Miyazaki I., Asanuma M., Takeshima M., Wagner G.C. Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. Int Rev Neurobiol 2009, 88:43-64.
36. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
37. Lanthier J., Desrosiers R.R. Protein L-isoaspartyl methyltransferase repairs abnormal aspartyl residues accumulated in vivo in type-I collagen and restores cell migration. Exp Cell Res 2004, 293:96-105.
38. Lanthier J., Desrosiers R.R. Regulation of protein L-isoaspartyl methyltransferase by cell-matrix interactions: involvement of integrin alphavbeta3, PI 3-kinase, and the proteasome. Biochem Cell Biol 2006, 84:684-694.
39. Lapointe M., Lanthier J., Moumdjian R., Régina A., Desrosiers R.R. Expression and activity of L-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors. Brain Res Mol Brain Res 2005, 135:93-103.
40. Lev N., Ickowicz D., Barhum Y., Lev S., Melamed E., Offen D. DJ-1 protects against dopamine toxicity. J Neural Transm 2009, 116:151-160.
41. Lev N., Barhum Y., Pilosof N.S., Ickowicz D., Cohen H.Y., Melamed E., Offen D. DJ-1 protects against dopamine toxicity: implications for Parkinson's disease and aging. J Gerontol A Biol Sci Med Sci 2013, 68:215-225.
42. Lin T.K., Liou C.W., Chen S.D., Chuang Y.C., Tiao M.M., Wang P.W., Chen J.B., Chuang J.H. Mitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease. Chang Gung Med J 2009, 32:589-599.
43. Lotharius J., Brundin P. Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease. Hum Mol Genet 2002, 11:2395-2407.
44. Lu T., Pan Y., Kao S.Y., Li C., Kohane I., Chan J., Yankner B.A. Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429:883-891.
45. MacLaren D.C., Kagan R.M., Clarke S. Alternative splicing of the human isoaspartyl protein carboxyl methyltransferase RNA leads to the generation of a C-terminal -RDEL sequence in isozyme II. Biochem Biophys Res Commun 1992, 185:277-283.
46. Michel P.P., Hefti F. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 1990, 26:428-435.
47. Miyazaki I., Asanuma M. Dopaminergic neuron-specific oxidative stress caused by dopamine itself. Acta Med Okayama 2008, 62:141-150.
48. Mizobuchi M., Murao K., Takeda R., Kakimoto Y. Tissue-specific expression of isoaspartyl protein carboxyl methyltransferase gene in rat brain and testis. J Neurochem 1994, 62:322-328.
49. Perfeito R., Cunha-Oliveira T., Cristina Rego A. Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson's disease - resemblance to the effect of amphetamine drugs of abuse. Free Radic Biol Med 2012, 53:1791-1806.
50. Shih J.C., Chen K., Ridd M.J. Monoamine oxidase: from genes to behavior. Annu Rev Neurosci 1999, 22:197-217.
51. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
52. Sun W., Choi S.H., Park S.K., Kim S.J., Noh M.R., Kim E.H., Kim H.J., Kim H. Identification and characterization of novel activity-dependent transcription factors in rat cortical neurons. J Neurochem 2007, 100:269-278.
53. Thomas B., Beal M.F. Parkinson's disease. Hum Mol Genet 2007, 16(Spec No. 2):R183-R194.
54. Wägner A.M., Cloos P., Bergholdt R., Eising S., Brorsson C., Stalhut M., Christgau S., Nerup J., Pociot F. Posttranslational protein modifications in type 1 diabetes - genetic studies with PCMT1, the repair enzyme protein isoaspartate methyltransferase (PIMT) encoding gene. Rev Diabet Stud 2008, 5:225-231.
55. Wang R., Qing H., Liu X.Q., Zheng X.L., Deng Y.L. Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells. Neurosci Bull 2008, 24:125-132.
56. Watabe M., Nakaki T. Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells. Mol Pharmacol 2008, 74:933-940.
57. Xia Q., Liao L., Cheng D., Duong D.M., Gearing M., Lah J.J., Levey A.I., Peng J. Proteomic identification of novel proteins associated with Lewy bodies. Front Biosci 2008, 13:3850-3856.
58. Xie H.R., Hu L.S., Li G.Y. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin Med J (Engl) 2010, 123:1086-1092.
59. Yamakawa K., Izumi Y., Takeuchi H., Yamamoto N., Kume T., Akaike A., Takahashi R., Shimohama S., Sawada H. Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun 2010, 391:129-134.
60. Yan G., Qin Q., Yi B., Chuprun K., Sun H., Huang S., Sun J. Protein-L-isoaspartate (D-aspartate) O-methyltransferase protects cardiomyocytes against hypoxia induced apoptosis through inhibiting proapoptotic kinase Mst1. Int J Cardiol 2013, 168:3291-3299.
61. Ye Q., Zhang X., Huang B., Zhu Y., Chen X. Astaxanthin suppresses MPP(+)-induced oxidative damage in PC12 cells through a Sp1/NR1 signaling pathway. Mar Drugs 2013, 11:1019-1034.
62. Yong-Kee C.J., Warre R., Monnier P.P., Lozano A.M., Nash J.E. Evidence for synergism between cell death mechanisms in a cellular model of neurodegeneration in Parkinson's disease. Neurotox Res 2012, 22:355-364.